This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Balajee, S. A. Articles by Marr, K. A. Search for Related Content PubMed PubMed Citation Articles by Balajee, S. A. Articles by Marr, K. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2002, p. 2741-2745, Vol. 40, No. 8
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.8.2741-2745.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Conidial Viability Assay for Rapid Susceptibility Testing of Aspergillus Species

Fred Hutchinson Cancer Research Center,¹ University of Washington, Seattle, Washington 98109²

Received 15 January 2002/ Returned for modification 14 April 2002/ Accepted 12 May 2002

Antifungal susceptibility testing of filamentous fungi has become more important given the recognition of drug-resistant organisms and the availability of therapies other than amphotericin B (AMB). As current microdilution and E-test methods are limited by a 2 to 3 day incubation time required to obtain results, a more rapid method for susceptibility testing of fungi is needed. We report here a flow cytometric assay that relies on conidial metabolism of the viability dye FUN-1. Conidia are incubated in media containing increasing concentrations of AMB for 3 h, exposed to FUN-1, and then analyzed by flow cytometry. Relative susceptibility to AMB can be measured both by forward and side scatter characteristics of the conidial population and by mean fluorescence intensity (MFI) of the dye. MIC, calculated as the concentration of AMB to yield 90% reduction in MFI relative to growth controls, was determined for 27 clinical isolates Aspergillus species and correlated well with the standard (i.e., NCCLS) method. The results of these studies illustrate a method by which AMB susceptibility can be rapidly and reproducibly determined by measuring conidial viability.

This article has been cited by other articles:

• Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., Walsh, T. J. (2007). Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species. J Antimicrob Chemother 59: 230-237 [Abstract] [Full Text]  
• Antachopoulos, C., Meletiadis, J., Roilides, E., Sein, T., Walsh, T. J. (2006). Rapid Susceptibility Testing of Medically Important Zygomycetes by XTT Assay. J. Clin. Microbiol. 44: 553-560 [Abstract] [Full Text]  
• Balajee, S. A., Imhof, A., Gribskov, J. L., Marr, K. A. (2005). Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay. J Antimicrob Chemother 55: 102-105 [Abstract] [Full Text]  
• Ramani, R., Gangwar, M., Chaturvedi, V. (2003). Flow Cytometry Antifungal Susceptibility Testing of Aspergillus fumigatus and Comparison of Mode of Action of Voriconazole vis-a-vis Amphotericin B and Itraconazole. Antimicrob. Agents Chemother. 47: 3627-3629 [Abstract] [Full Text]  
• Meletiadis, J., te Dorsthorst, D. T. A., Verweij, P. E. (2003). Use of Turbidimetric Growth Curves for Early Determination of Antifungal Drug Resistance of Filamentous Fungi. J. Clin. Microbiol. 41: 4718-4725 [Abstract] [Full Text]